Peter Sand to Acetylcholine Release Inhibitors
This is a "connection" page, showing publications Peter Sand has written about Acetylcholine Release Inhibitors.
Connection Strength
0.178
-
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223.
Score: 0.144
-
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800.
Score: 0.034